609
Participants
Start Date
April 1, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2027
Folfirinox
The primary aim of this trial was to investigate whether six cycles of preoperative mFOLFIRINOX followed by six cycles of postoperative mFOLFIRINOX improved the overall survival rate by intention-to-treat compared to surgery followed by 12 cycles of postoperative mFOLFIRINOX.
RECRUITING
Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine, Seoul
RECRUITING
Department of Surgery, Seoul National University College of Medicine, Seoul
Seoul National University Bundang Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
Gangnam Severance Hospital
OTHER
Seoul St. Mary's Hospital
OTHER
Seoul National University Hospital
OTHER